Alexandros Arvanitakis

1 – 8 of 8

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/8d290c2d-ab2b-4826-acfb-110044a1d80f?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2024
Mark Haemophilia A - In pursuit of optimised outcomes via personalised treatment
Arvanitakis, Alexandros ^LU (2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
Mark Comparative clinical efficacy and safety of biosimilar ABP 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria
Kulasekararaj, Austin ; Lanza, Francesco ; Arvanitakis, Alexandros ^LU ; Langemeijer, Saskia ; Chonat, Satheesh ; Tombak, Anil ; Hanes, Vladimir ; Cao, Jia ; Miller, Mieke Jill and Colbert, Alexander , et al. (2024) In American Journal of Hematology 99(11). p.2108-2117
- Contribution to journal › Article
Mark Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients
Arvanitakis, Alexandros ^LU ; Jepsen, Caroline ; Andersson, Nadine G. ^LU ; Baghaei, Fariba and Astermark, Jan ^LU (2024) In Haemophilia 30(3). p.671-677
- Contribution to journal › Article
Mark Sicklecellsjukdom - vanliga och farliga komplikationer
Björkman, Hedvig ; Fager Ferrari, Marcus ^LU ; Arvanitakis, Alexandros ^LU and Kjellander, Christian (2024) In Läkartidningen 121.
- Contribution to journal › Article
2023
Mark Impact of timing of prophylaxis commencement, F8 genotype and age on factor consumption and health-related quality of life in patients with severe haemophilia A
Arvanitakis, Alexandros ^LU ; Holme, Pål Andre ; Berntorp, Erik ^LU and Astermark, Jan ^LU (2023) In Haemophilia 29(4). p.1032-1038
- Contribution to journal › Article
2022
Mark Clinical outcome and adherence rate in Scandinavian patients with intermediate-intensity prophylaxis before and after the switch of standard half-life FVIII products to BAY 81–8973
Arvanitakis, Alexandros ^LU ; Holme, Pål Andre ; Berntorp, Erik ^LU and Astermark, Jan ^LU (2022) In Haemophilia 28(2). p.223-229
- Contribution to journal › Article
2021
Mark A comparison of MyPKFiT and WAPPS-Hemo as dosing tools for optimizing prophylaxis in patients with severe haemophilia A treated with Octocog alfa
Arvanitakis, Alexandros ^LU ; Berntorp, Erik ^LU and Astermark, Jan ^LU (2021) In Haemophilia 27(3). p.417-424
- Contribution to journal › Article
2013
Mark Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
Askmyr, Maria ^LU ; Ågerstam, Helena ^LU ; Hansen, Nils ^LU ; Gordon, Sandra ^LU ; Arvanitakis, Alexandros ^LU ; Rissler, Marianne ^LU ; Juliusson, Gunnar ^LU ; Richter, Johan ^LU ; Järås, Marcus ^LU and Fioretos, Thoas ^LU (2013) In Blood 121(18). p.3709-3713
- Contribution to journal › Article